iBio, Inc. Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Revenue	0.1	0.4	0.23	-	1.88
Revenue Growth	-75.00%	77.78%	-	-	-20.54%
Gross Profit	0.1	0.4	0.23	-	1.88
Selling, General & Admin	10.6	10.69	11.67	18.45	21.75
Research & Development	19.64	8.31	5.19	10.33	9.83
Operating Expenses	30.24	19	16.86	28.78	31.58
Operating Income	-30.14	-18.6	-16.63	-28.78	-29.7
Interest Expense	-0.05	-0.21	-0.17	-0.08	-
Interest & Investment Income	2.15	0.44	0.36	0.21	0.18
Other Non Operating Income (Expenses)	-	-	-	-	0.01
EBT Excluding Unusual Items	-28.04	-18.38	-16.44	-28.65	-29.51
Gain (Loss) on Sale of Investments	-	-	-	-0.1	-
Gain (Loss) on Sale of Assets	-	-	1	-	-
Asset Writedown	-5	-	-	-0.57	-
Pretax Income	-33.04	-18.38	-15.44	-29.31	-29.51
Earnings From Continuing Operations	-33.04	-18.38	-15.44	-29.31	-29.51
Earnings From Discontinued Operations	-	-	-9.46	-35.7	-20.79
Net Income to Company	-33.04	-18.38	-24.91	-65.01	-50.3
Minority Interest in Earnings	-	-	-	-	0
Net Income	-33.04	-18.38	-24.91	-65.01	-50.3
Preferred Dividends & Other Adjustments	-	-	-	-	0.09
Net Income to Common	-33.04	-18.38	-24.91	-65.01	-50.39
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	104	10	4	1	0
Shares Outstanding (Diluted)	104	10	4	1	0
Shares Change	891.14%	174.05%	525.98%	40.35%	11.45%
EPS (Basic)	-0.32	-1.75	-6.50	-106.23	-115.56
EPS (Diluted)	-0.32	-1.75	-6.50	-106.23	-115.56
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Free Cash Flow	-23.8	-15.32	-18.76	-36.87	-44.81
Free Cash Flow Per Share	-0.23	-1.46	-4.90	-60.24	-102.76
Gross Margin	100.00%	100.00%	100.00%	-	100.00%
Operating Margin	-30138.00%	-4650.50%	-7392.89%	-	-1576.27%
Profit Margin	-33044.00%	-4594.25%	-11069.78%	-	-2674.68%
Free Cash Flow Margin	-23796.00%	-3830.00%	-8339.56%	-	-2378.45%
EBITDA	-29.49	-17.83	-15.71	-28.05	-29.3
D&A For EBITDA	0.65	0.78	0.93	0.73	0.4
EBIT	-30.14	-18.6	-16.63	-28.78	-29.7

SEC Filings: 10-K · 10-Q